| Matthew Guymon, DO | |
|
1226 Ne 7th St, Grants Pass, OR 97526 | |
| (810) 606-5000 | |
| Not Available |
| Full Name | Matthew Guymon |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 13 Years |
| Location | 1226 Ne 7th St, Grants Pass, Oregon |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205120730 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | DO172760 (Oregon) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Asante Three Rivers Medical Center | Grants pass, OR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cascade Eyecare Center Pc | 7113999236 | 4 |
News Archive
A new study suggested that an estimated 7% of American teens and adults carry the human papillomavirus in their mouths. This may help health experts finally understand why rates of mouth and throat cancer have been climbing for nearly 25 years. The evidence additionally makes it clear that oral sex practices play a key role in transmission.
Kaiser Health News: "Starting today, states can choose to take the first steps toward the massive expansion of insurance coverage that is the health overhaul's chief goal. And for some states, that move could have the benefit of reviving funding for state-run programs that insure low-income adults. As of April 1, states can apply for federal funding to expand their Medicaid programs to cover low-income people earning up to 133 percent of the poverty level, or $14,404 for an individual and $29,326.50 for a family of four.
RegeneRx Biopharmaceuticals, Inc. announced that it has received Orphan Drug designation from U.S. FDA's Office of Orphan Products Development for its drug candidate, Thymosin beta 4 (Tβ4), for the treatment of Neurotrophic Keratopathy, a serious degenerative disease of the corneal epithelium (the outside layer of the eye).
Targeted Medical Pharma, Inc., a biotechnology company that develops and distributes prescription medical foods to physicians and pharmacies, today announced the launch of a new division that will specialize in the manufacturing and distribution of a proprietary line of dietary supplements.
Parkinson's disease is one of the commonest afflictions caused by damage to the nerve cells of the brain. Patients suffer from muscular tremors and rigidity, and their movements are severely impaired.
› Verified 9 days ago
| Entity Name | Cascade Eyecare Center Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295758696 PECOS PAC ID: 7113999236 Enrollment ID: O20040810000394 |
News Archive
A new study suggested that an estimated 7% of American teens and adults carry the human papillomavirus in their mouths. This may help health experts finally understand why rates of mouth and throat cancer have been climbing for nearly 25 years. The evidence additionally makes it clear that oral sex practices play a key role in transmission.
Kaiser Health News: "Starting today, states can choose to take the first steps toward the massive expansion of insurance coverage that is the health overhaul's chief goal. And for some states, that move could have the benefit of reviving funding for state-run programs that insure low-income adults. As of April 1, states can apply for federal funding to expand their Medicaid programs to cover low-income people earning up to 133 percent of the poverty level, or $14,404 for an individual and $29,326.50 for a family of four.
RegeneRx Biopharmaceuticals, Inc. announced that it has received Orphan Drug designation from U.S. FDA's Office of Orphan Products Development for its drug candidate, Thymosin beta 4 (Tβ4), for the treatment of Neurotrophic Keratopathy, a serious degenerative disease of the corneal epithelium (the outside layer of the eye).
Targeted Medical Pharma, Inc., a biotechnology company that develops and distributes prescription medical foods to physicians and pharmacies, today announced the launch of a new division that will specialize in the manufacturing and distribution of a proprietary line of dietary supplements.
Parkinson's disease is one of the commonest afflictions caused by damage to the nerve cells of the brain. Patients suffer from muscular tremors and rigidity, and their movements are severely impaired.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Matthew Guymon, DO 1226 Ne 7th St, Grants Pass, OR 97526-1424 Ph: (541) 476-6636 | Matthew Guymon, DO 1226 Ne 7th St, Grants Pass, OR 97526 Ph: (810) 606-5000 |
News Archive
A new study suggested that an estimated 7% of American teens and adults carry the human papillomavirus in their mouths. This may help health experts finally understand why rates of mouth and throat cancer have been climbing for nearly 25 years. The evidence additionally makes it clear that oral sex practices play a key role in transmission.
Kaiser Health News: "Starting today, states can choose to take the first steps toward the massive expansion of insurance coverage that is the health overhaul's chief goal. And for some states, that move could have the benefit of reviving funding for state-run programs that insure low-income adults. As of April 1, states can apply for federal funding to expand their Medicaid programs to cover low-income people earning up to 133 percent of the poverty level, or $14,404 for an individual and $29,326.50 for a family of four.
RegeneRx Biopharmaceuticals, Inc. announced that it has received Orphan Drug designation from U.S. FDA's Office of Orphan Products Development for its drug candidate, Thymosin beta 4 (Tβ4), for the treatment of Neurotrophic Keratopathy, a serious degenerative disease of the corneal epithelium (the outside layer of the eye).
Targeted Medical Pharma, Inc., a biotechnology company that develops and distributes prescription medical foods to physicians and pharmacies, today announced the launch of a new division that will specialize in the manufacturing and distribution of a proprietary line of dietary supplements.
Parkinson's disease is one of the commonest afflictions caused by damage to the nerve cells of the brain. Patients suffer from muscular tremors and rigidity, and their movements are severely impaired.
› Verified 9 days ago
Dr. Douglas R. Merritt, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1226 Ne 7th St, Grants Pass, OR 97526 Phone: 541-476-6636 Fax: 541-476-6690 | |
Dr. Russell Leavitt, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1226 Ne 7th St, Grants Pass, OR 97526 Phone: 541-476-6636 Fax: 541-476-6690 | |
Dr. Mark Maffett, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1226 Ne 7th St, Grants Pass, OR 97526 Phone: 541-476-6636 Fax: 541-476-6690 | |
Dr. James Lowell Davidian, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 1226 Ne 7th St, Grants Pass, OR 97526 Phone: 541-476-6636 Fax: 541-476-6690 | |
Rodney Derrick Leavitt, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1226 Ne 7th St, Grants Pass, OR 97526 Phone: 541-476-6636 Fax: 541-476-6690 |